| 东菱克栓酶与蝮蛇抗栓酶治疗急性动脉硬化性脑梗塞的疗效比较 |
| |
| 引用本文： | 何巧玲,张秀侠.东菱克栓酶与蝮蛇抗栓酶治疗急性动脉硬化性脑梗塞的疗效比较[J].湛江医学院学报,1997,15(1):23-25. |
| |
| 作者姓名： | 何巧玲 张秀侠 |
| |
| 作者单位： | 广东省农垦中心医院神经内科!湛江524002 |
| |
| 摘 要： | 目的：观察东菱克栓酶（ＤＦ－５２１）与蝮蛇抗栓酶（Ｓｖａｔｅ）对急性动脉粥样硬化性血栓性脑梗塞（ＡＡＣＩ）的疗效比较。方法：经ＣＴ或ＭＲＩ确诊的ＡＡＣＩ７８例随机分为２组即ＤＦ－５２１组４８例和Ｓｖａｔｅ组３０例。结果：总有效率：ＤＦ－５２１组为８９．６％，Ｓｖａｔｅ组为７６．６％（Ｐ〉０．０５）；两组的显效率分别为７０．８％、３６．７％（Ｐ〈０．０１）。结论：ＤＦ－５２１的疗效明显优于Ｓｖａｔｅ
|
| 关 键 词： | 急性 脑梗塞 药物疗法 东菱克栓酶 蝮蛇抗栓酶 |
A COMPARISON OF EFFECTS BETWEEN BATROXOBIN AND AHYLYSANTINFARETASE ON ACUTE ARTERIOSCLEROTIC CEREBRAL INFARCTION |
| |
| He Qiaoling, Zhang Xiuxia.A COMPARISON OF EFFECTS BETWEEN BATROXOBIN AND AHYLYSANTINFARETASE ON ACUTE ARTERIOSCLEROTIC CEREBRAL INFARCTION[J].Journal of Guangdong Medical College,1997,15(1):23-25. |
| |
| Authors: | He Qiaoling Zhang Xiuxia |
| |
| Abstract: | Objective: To compare the effects between Batroxobin (DF-521) and Ahylysantinfaretase (Svate)on acute arteriosclerotic cerebral infarction(AACI). Metbods: Seventy-eight patients with AACI were divided randomly into two groups,i. e. DF-521 and Svate groups. The patients of DF-521 group(n= 48) received intravenous drip of DF-521 10U dissolved in normal saline at the 1st day. DF-521 5U at the 3rd and the 5th days, respectively. The ones of Svate group (n = 30) received intravenous drip of Svate 0. 75U daily dissolved in 250ml normal saline for 15 days. Results: Notable effective rate of DF-521 group was significantly higher than that of Svate group(70. 8% vs 36. 7%, P<0. 01). Conclusion: The efficacy of DF-521 is obviously superior to that of Svate in the treatment of AACI. |
| |
| Keywords: | tobishi batroxobin ahylysantinfaretase acute cerebral infartion |
| 本文献已被 CNKI 维普 等数据库收录！ |
